Ovarian cancer spreads most commonly by shedding cells directly into the abdominal cavity, a process called transcoelomic metastasis. This route is responsible for more illness and death than any other pattern of spread in the disease. Unlike many cancers that travel first through the bloodstream, ovarian cancer cells tend to detach from the tumor surface and drift through the fluid that naturally surrounds the abdominal organs, seeding new growths on nearby tissues before ever reaching distant sites.
Transcoelomic Spread: The Primary Route
The hallmark of ovarian cancer metastasis is its tendency to spread across the peritoneal cavity, the membrane-lined space that houses the intestines, stomach, liver surface, and other abdominal organs. Tumor cells break away from the ovary’s surface in a relatively passive process. Once free-floating, they’re carried by the natural movement of peritoneal fluid, which circulates continuously as you breathe, move, and digest food. These mechanical currents act as a transport system, delivering cancer cells to surfaces throughout the abdomen.
The omentum, a fatty tissue apron that drapes over the intestines between the stomach and colon, is the single most common destination. This isn’t random. The omentum contains tiny vascularized structures called milky spots, clusters of immune cells and blood vessels that paradoxically create a hospitable environment for cancer cells. These milky spots provide the blood supply and cellular interactions that tumor cells need to take root and grow. Researchers describe this as a “seed and soil” relationship: the cancer cells are seeds, and the omentum’s milky spots are unusually fertile soil.
Beyond the omentum, cancer cells carried by peritoneal fluid commonly implant on the surfaces of the bowel, the diaphragm (the muscle separating the chest from the abdomen), and the peritoneal lining itself. These implants often appear as countless tiny nodules scattered across organ surfaces rather than a single large mass, a pattern sometimes described as miliary spread. When these nodules coat the surface of the small bowel or colon extensively, they become one of the most difficult aspects of the disease to treat surgically, because removing all of them could require taking out too much intestine.
The Role of Ascites in Fueling Spread
As ovarian cancer advances, many women develop ascites, an abnormal buildup of fluid in the abdominal cavity. This fluid isn’t just a symptom. It actively accelerates the cancer’s spread. Ascites carries individual tumor cells, clusters of cells, and signaling molecules to new intraperitoneal sites, essentially creating a self-reinforcing cycle: more cancer leads to more fluid, and more fluid carries cancer cells further.
The fluid buildup itself results from several overlapping problems. Tumors can obstruct the lymphatic vessels that normally drain fluid from the abdomen. Cancer also increases the permeability of blood vessels in the area, causing them to leak. Research shows a correlation between the number of lymph nodes involved and the likelihood of developing ascites, suggesting that lymphatic blockage plays a meaningful role, though fluid can accumulate even without obvious obstruction.
Lymphatic Spread
Ovarian cancer also travels through the lymphatic system, though less commonly than through peritoneal seeding. The ovaries drain through several lymphatic pathways, and the specific nodes involved reflect this anatomy. The para-aortic lymph nodes, which sit alongside the large blood vessel running down the spine, are the most frequently affected. In studies mapping the first lymph nodes to receive drainage from ovarian tumors, about 67% were found in the para-aortic region, with roughly equal numbers near the kidneys and lower in the abdomen.
A second pathway drains through the ovarian ligament into pelvic lymph nodes near the internal iliac artery and obturator fossa. In roughly a third of cases, both pelvic and para-aortic nodes are involved simultaneously. A third, less common route drains through the round ligament to the inguinal (groin) lymph nodes. This multi-directional drainage is one reason surgical staging for ovarian cancer includes sampling lymph nodes from both the pelvis and the para-aortic region.
Bloodstream Spread to Distant Organs
Hematogenous metastasis, spread through the bloodstream to organs outside the abdomen, occurs but is less characteristic of ovarian cancer than peritoneal seeding. When it does happen, the liver is the most common single distant site, accounting for about 53% of cases with a single distant metastasis. The lungs are next at roughly 42%. Bone metastases are uncommon (about 4.5%), and brain involvement is rare (under 1%).
It’s worth noting that the liver can be involved in two distinct ways. Cancer cells can implant on the liver’s surface as part of peritoneal seeding, which is common and considered abdominal spread. True hematogenous liver metastasis means cancer cells traveled through the blood and grew within the liver tissue itself, which is a different and more advanced pattern.
Why Most Cases Are Found After Spread
The way ovarian cancer spreads explains why it’s so often diagnosed late. Peritoneal seeding can progress silently for months. Small implants scattered across abdominal surfaces may not cause obvious symptoms until they’re widespread enough to produce ascites, bowel changes, or abdominal bloating. In a global analysis of over 233,000 women with ovarian cancer, only about 16% were diagnosed with localized disease. Roughly 72% already had advanced disease at diagnosis, meaning the cancer had spread to regional lymph nodes, distant organs, or extensively throughout the peritoneal cavity.
How Spread Patterns Shape Treatment
Because ovarian cancer tends to carpet abdominal surfaces rather than form a few discrete masses in distant organs, surgery focuses on removing as many visible implants as possible. The current standard defines optimal surgery as leaving no tumor nodule larger than 1 cm in diameter, though outcomes improve further when surgeons achieve what’s called a complete resection, leaving no visible disease at all. Some centers now push for an even stricter threshold, aiming to leave nothing larger than 2.5 mm.
The biggest obstacle to complete surgical removal is extensive involvement of the bowel surfaces. When tiny nodules coat the small intestine or colon, removing them all would mean cutting away more bowel than the body can function without. This is the most common reason a surgeon may not be able to achieve a complete resection. The peritoneal spread pattern also explains why chemotherapy for ovarian cancer is sometimes delivered directly into the abdominal cavity rather than only through a vein, targeting the space where most of the disease lives.